Literature DB >> 20376083

Targeting lysosomes to eradicate imatinib-resistant chronic myelogenous leukemia cells.

A Puissant, M Dufies, S Raynaud, J-P Cassuto, P Auberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20376083     DOI： 10.1038/leu.2010.55

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux.

Authors:  Sandy Giuliano; Yann Cormerais; Maeva Dufies; Renaud Grépin; Pascal Colosetti; Amine Belaid; Julien Parola; Anthony Martin; Sandra Lacas-Gervais; Nathalie M Mazure; Rachid Benhida; Patrick Auberger; Baharia Mograbi; Gilles Pagès
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

2.  Combating non-Hodgkin lymphoma by targeting both CD20 and HLA-DR through CD20-243 CrossMab.

Authors:  Lei Zhao; Feiyue Xie; Xin Tong; Huafei Li; Yaling Chen; Weizhu Qian; Shuyan Duan; Juan Zheng; Ziye Zhao; Bohua Li; Dapeng Zhang; Jian Zhao; Jianxin Dai; Hao Wang; Sheng Hou; Yajun Guo
Journal:  MAbs       Date:  2014-03-26       Impact factor: 5.857

3.  Gleevec shifts APP processing from a β-cleavage to a nonamyloidogenic cleavage.

Authors:  William J Netzer; Karima Bettayeb; Subhash C Sinha; Marc Flajolet; Paul Greengard; Victor Bustos
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-23       Impact factor: 11.205

4.  Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence.

Authors:  C Drullion; C Trégoat; V Lagarde; S Tan; R Gioia; M Priault; M Djavaheri-Mergny; A Brisson; P Auberger; F-X Mahon; J-M Pasquet
Journal:  Cell Death Dis       Date:  2012-08-16       Impact factor: 8.469

5.  All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to ponatinib.

Authors:  Ophélie Cassuto; Maeva Dufies; Arnaud Jacquel; Guillaume Robert; Clémence Ginet; Alix Dubois; Amine Hamouda; Alexandre Puissant; Fredéric Luciano; Jean-Michel Karsenti; Laurence Legros; Jill Patrice Cassuto; Pascal Lenain; Patrick Auberger
Journal:  Oncotarget       Date:  2012-12

6.  Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells.

Authors:  Maeva Dufies; Arnaud Jacquel; Nathalie Belhacene; Guillaume Robert; Thomas Cluzeau; Fréderic Luciano; Jill Patrice Cassuto; Sophie Raynaud; Patrick Auberger
Journal:  Oncotarget       Date:  2011-11

7.  High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts.

Authors:  Jinghan Wang; Fenglin Li; Zhixin Ma; Mengxia Yu; Qi Guo; Jiansong Huang; Wenjuan Yu; Yungui Wang; Jie Jin
Journal:  EBioMedicine       Date:  2018-01-31       Impact factor: 8.143

8.  BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients.

Authors:  Thomas Cluzeau; Guillaume Robert; Nicolas Mounier; Jean Michel Karsenti; Maeva Dufies; Alexandre Puissant; Arnaud Jacquel; Aline Renneville; Claude Preudhomme; Jill-Patrice Cassuto; Sophie Raynaud; Frederic Luciano; Patrick Auberger
Journal:  Oncotarget       Date:  2012-04

9.  Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells.

Authors:  Josep M Cornet-Masana; Antònia Banús-Mulet; José M Carbó; Miguel Ángel Torrente; Francesca Guijarro; Laia Cuesta-Casanovas; Jordi Esteve; Ruth M Risueño
Journal:  EBioMedicine       Date:  2019-08-28       Impact factor: 8.143

10.  Somatostatin receptor mediated targeting of acute myeloid leukemia by photodynamic metal complexes for light induced apoptosis.

Authors:  Naidu M Vegi; Sabyasachi Chakrabortty; Maksymilian M Zegota; Seah Ling Kuan; Anne Stumper; Vijay P S Rawat; Stefanie Sieste; Christian Buske; Sven Rau; Tanja Weil; Michaela Feuring-Buske
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.